GORE® EXCLUDER® AAA Endoprosthesis
GPTKB entity
Statements (38)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:hospital
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Gore_Endovascular
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:clinical_trial |
GORE® EXCLUDER® Clinical Study
used in endovascular aneurysm repair (EVAR) |
| gptkbp:complications |
endoleak
|
| gptkbp:contraindication |
severe vascular disease
uncontrolled infection anatomical limitations |
| gptkbp:education |
informed consent required
|
| gptkbp:events |
regular imaging required
|
| gptkbp:features |
dual-layer design
|
| gptkbp:feedback |
generally high
|
| gptkbp:first_introduced |
gptkb:2002
|
| gptkbp:follows |
annual follow-up recommended
|
| gptkbp:healthcare |
monitor for complications
|
| https://www.w3.org/2000/01/rdf-schema#label |
GORE® EXCLUDER® AAA Endoprosthesis
|
| gptkbp:innovation |
improved delivery system
|
| gptkbp:is_available_in |
various sizes
|
| gptkbp:is_designed_for |
treatment of abdominal aortic aneurysms
|
| gptkbp:manufacturer |
gptkb:W._L._Gore_&_Associates
|
| gptkbp:marketed_as |
gptkb:GORE®_EXCLUDER®_AAA_Endoprosthesis
|
| gptkbp:material |
e PTFE
|
| gptkbp:outcome |
monitored for durability
|
| gptkbp:population |
adults
|
| gptkbp:provides_information_on |
follow vascular surgery guidelines
|
| gptkbp:risk_factor |
gptkb:healthcare_organization
gptkb:High_School hypertension smoking family history of aneurysms thrombus formation |
| gptkbp:specialties |
percutaneous access
|
| gptkbp:succeeded_by |
high success rate
|
| gptkbp:treatment |
reduces risk of aneurysm rupture
|
| gptkbp:type |
endovascular stent graft
|
| gptkbp:used_in |
minimally invasive surgery
|